Показано 0 из 0
Дата |
---|
20:00 |
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.43
|
0.45
|
0.45
|
0.4216
|
0.476899
|
0.442
|
|
|
7 520.73
|
60.00
|
0.4103
|
0.58
|
0.4499
|
0.43
|
0.49
|
0.458051
|
|
|
5 780.80
|
36.00
|
0.41
|
0.5274
|
0.479
|
0.45
|
0.479
|
0.45
|
|
|
1 594.35
|
26.00
|
0.4112
|
0.466
|
0.44
|
0.4252
|
0.458001
|
0.45
|
|
|
19 129.15
|
94.00
|
0.4103
|
0.466
|
0.487951
|
0.4004
|
0.488
|
0.4497
|
|
|
16 257.06
|
140.00
|
0.45
|
0.4925
|
0.52
|
0.4328
|
0.52
|
0.471
|
|
|
39 050.69
|
246.00
|
0.50
|
0.52
|
0.60
|
0.49348
|
0.60
|
0.5057
|
|
|
94 046.55
|
485.00
|
0.5001
|
0.526
|
0.63
|
0.5518
|
0.6574
|
0.632
|
|
|
279 474.65
|
834.00
|
0.582
|
0.66
|
0.641
|
0.57
|
0.6548
|
0.57
|
|
|
23 528.10
|
92.00
|
0.6301
|
0.665
|
0.64
|
0.636601
|
0.6684
|
0.644
|
|
|
4 895.96
|
70.00
|
Lipella Pharmaceuticals Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing proprietary drug delivery platform that optimizes drug delivery to mucosal membranes for the treatment of cancer survivors. Lipella Pharmaceuticals serves customers in the United States.